The COVID-19 pandemic revealed several weaknesses in healthcare supply chains globally. In the United States, about 75% of healthcare leaders expect supply chain challenges to either get worse or remain the same in the next year. These challenges mainly arise from higher labor costs, limited labor availability, inflation, and ongoing product shortages. The call for domestic manufacturing in the healthcare sector has become vital for improving supply chain stability. Many experts, including those from Premier, are pushing for bringing production back to the U.S. as a crucial step to tackle these issues.
Recent surveys show that roughly 93% of healthcare provider executives are dealing with persistent product shortages. This issue is further complicated by geopolitical tensions and trade disputes, which leave healthcare providers vulnerable when depending heavily on international suppliers for essential medical products. As healthcare administrators and practice owners face these challenges, it is increasingly important to have control over the supply of critical resources.
In 2023, the healthcare sector has seen rising expenses primarily due to supply chain issues. KPMG reports that supply expenses are a major reason for increased costs for hospitals and healthcare organizations. What was once a singular challenge of product shortages has turned into a recurring issue, with interruptions becoming more common and affecting various medical supplies. This unpredictability leads to canceled or rescheduled procedures, impacting patient care. Almost 48.6% of leaders surveyed indicated that they had to cancel or postpone procedures quarterly because of product shortages.
To address these challenges, domestic manufacturing is playing an important role in ensuring supply chain stability. Three out of four healthcare leaders believe that domestic manufacturing is an “extremely” or “very important” component of their supply chain strategies. This shift towards local production helps to tackle several vulnerabilities:
Bringing manufacturing back to the U.S. allows healthcare providers to manage better quality control and improve regulatory compliance. U.S. standards ensure that medical products go through quality checks that may not exist when facilities are overseas. Better compliance also reduces the risks linked to product recalls, which can be serious for patient safety.
Investing in local production for healthcare supplies helps create jobs and boosts the domestic economy. According to data from President Biden’s administration, over 367,000 manufacturing jobs were added in 2021. By supporting domestic manufacturing capabilities, organizations can secure essential medical products while also benefiting local communities economically.
Reducing production distances leads to lesser carbon emissions from long-distance shipping. The Reshoring Institute states that shipping accounts for over one billion tons of CO2 and greenhouse gases each year. Domestic manufacturing can help reduce these emissions and contribute to environmental sustainability.
Despite the clear benefits of domestic manufacturing, there are challenges connected to reshoring. Investment in infrastructure is necessary to support this transition. Healthcare organizations may need to invest considerably in new production facilities, workforce development, and better logistics. Additionally, the different regulatory standards across states add a layer of complexity, especially for sectors like pharmaceuticals that have stringent compliance demands.
Inflation and rising costs can make reshoring more complex. Healthcare organizations are facing shrinking margins, making it tough to reassess manufacturing practices without incurring extra costs. Therefore, ongoing investment in local resources is crucial.
Healthcare organizations must also diversify their supply chains. Sole reliance on domestic suppliers can pose risks. Organizations should consider multiple sourcing strategies to ensure a steady supply, alongside contingency plans for emergencies.
Besides reshoring efforts, the rapid growth of AI and automation technologies offers considerable potential for transforming healthcare supply chain management. These tools can enhance efficiencies, improve resource allocation, and aid decision-making for administrators, owners, and IT managers.
AI-driven solutions, like those from Simbo AI, can automate front-office phone interactions, helping healthcare organizations streamline communication while easing staff workload. This technology can significantly aid in managing supply chain disruptions by automating responses to inquiries about product availability, delivery timelines, and logistics.
AI platforms, such as the PINC AI™ Supply Disruption Manager, have shown over 90% accuracy in predicting demand surges and product shortages. Such predictive analytics give healthcare leaders vital foresight, allowing them to proactively adjust procurement strategies to prevent shortages. By using these advanced data analytic tools, organizations can turn supply chain challenges into manageable situations.
Automation can assist healthcare providers in streamlining routine tasks, allowing staff to focus on more critical functions. Reducing the time spent on administrative duties can lead to improved clinical workflows, enhancing patient care outcomes. Many providers indicate that automation can save teams over 10 hours each week that would otherwise be spent on phone interactions and manual data entry.
Better communication systems driven by AI can strengthen relationships with suppliers and distributor networks. Real-time tracking and logistics management become more attainable, enabling administrators to engage with suppliers to ensure compliance with new requirements, such as those mandated by reshoring efforts.
By integrating AI solutions into their operations, healthcare providers can position themselves to handle the complexities of supply chain management and patient care more effectively.
Shawn Janus highlights the need for collaboration in strengthening healthcare supply chains. Engaging with stakeholders, including suppliers, technology partners, and regulatory bodies, is essential for successful reshoring. Through strategic partnerships, organizations can share knowledge and invest in innovative capabilities, fostering a shared commitment to progress.
Government initiatives, such as the Defense Production Act (DPA), can provide critical support for healthcare supply chains. The DPA aims to enhance the availability of health resources, ensuring the domestic production and supply of essential products. This supportive framework highlights the importance of local production and demonstrates how public-private partnerships can effectively address supply gaps.
Furthermore, amending the Buy American Act is a step towards promoting local manufacturing. Changes to this act will create pricing preferences for essential domestic-made products, helping local manufacturers gain a foothold in the healthcare supply chain. These initiatives create an environment that encourages practitioners and administrators to prioritize domestic sourcing in their purchasing strategies.
The growing focus on domestic manufacturing signifies more than just a logistical change for healthcare supply chains. It reflects a rethinking of how providers procure, produce, and deliver products essential for patient safety and care. Moving ahead, continuous efforts must be made to support reshoring while also investing in technology, workforce development, and infrastructure.
For healthcare administrators and leaders across the United States, the challenge lies in balancing these elements while managing regulatory changes, geopolitical factors, and economic conditions. The undertaking is substantial, yet the possibilities for progress are significant.
In this new framework, domestic manufacturing is not just an operational necessity but a significant strategy for resilience. It enables healthcare organizations to respond to current and future challenges. By collaborating, investing in technologies like AI, and supporting local capabilities, healthcare leaders can develop strong supply chains that can handle the pressures of an uncertain future. This comprehensive approach will be crucial in ensuring that healthcare providers can deliver uninterrupted, quality care to their patients.
Simbo is making doctors' and patients' lives better. Connect now to know more.
Schedule Demo Now© Since 2019, Simbo AI.
